# Trade Mark Journal No.2026/025 19 June 2026

## WO0000001842873 (5,42,44)

Office of origin: United States of America

Date of International Registration:28 January 2025
Date of designation in the UK: 21 February 2026

Registration of this mark shall not give right to the exclusive use of "THERAPEUTICS".

Class 5
  Pharmaceutical preparations for use in the treatment of malignancies; pharmaceutical preparations, namely, antitumor agents; pharmaceutical preparations for use in humans for the treatment of cancer and immunological diseases; pharmaceutical preparations for the treatment of cancer and for use in oncology and immuno-oncology.
Class 42
  Drug discovery services for the identification and analysis of therapeutics for use in oncology and immuno-oncology; research and development services in the field of therapeutics for the treatment of cancer; research and development services in the fields of oncology and immuno-oncology; providing medical and scientific research information in the field of biopharmaceuticals; providing medical and scientific research information in the field of cancer.
Class 44
  Healthcare services, namely, providing patient treatment services in the fields of oncology and immuno-oncology; provision of medical services in the field of oncology and immuno-oncology for the treatment of patients; advice relating to oncology and immuno-oncology; providing medical care services in the field of oncology and immuno-oncology; providing medical information in the field of cancer; medical counseling in the field of oncology and immuno-oncology; clinical medical consulting in the field of oncology and immuno-oncology.

SUMMIT THERAPEUTICS SUB INC.

Representative: Andrea M. Porterfield Polsinelli PC, PO Box 140310, Kansas City MO 64114-0310, UNITED STATES OF AMERICA